PUBLICATIONS

Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab

No.59
Year2019
JournalHaematologica
InstituteNara Medical University
1st AuthorSakai K
AR
PL
Paper typesBasic research
Main
purpose
Disease
Antiplatelet drug
Anticoagulant drug
Other drugCaplacizumab
Clinical specimens
Animal
Keyword Arterial Thrombosis; Thrombotic Thrombocytopenic Purpura; aptamer; von Willebrand factor
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2020 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.